Gut microbiome can be restored without adverse events after Helicobacter pylori eradication therapy in teenagers
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Gut microbiome can be restored without adverse events after Helicobacter pylori
eradication therapy in teenagers
Authors
Keywords
-
Journal
HELICOBACTER
Volume 23, Issue 6, Pages e12541
Publisher
Wiley
Online
2018-10-12
DOI
10.1111/hel.12541
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gastric cancer: evidence boosts Helicobacter pylori eradication
- (2018) Hidekazu Suzuki et al. Nature Reviews Gastroenterology & Hepatology
- Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer
- (2018) Il Ju Choi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of probiotic-supplemented triple therapy for eradication of Helicobacter pylori in children: a systematic review and network meta-analysis
- (2017) Jue-Rong Feng et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- The administrative project of Helicobacter pylori infection screening among junior high school students in an area of Japan with a high incidence of gastric cancer
- (2017) Chika Kusano et al. Gastric Cancer
- Consensus on the clinical management, screening-to-treat, and surveillance of Helicobacter pylori infection to improve gastric cancer control on a nationwide scale
- (2017) Bor-Shyang Sheu et al. HELICOBACTER
- Vonoprazan- vs proton-pump inhibitor-based first-line 7-day triple therapy for clarithromycin-susceptible Helicobacter pylori : A multicenter, prospective, randomized trial
- (2017) Soichiro Sue et al. HELICOBACTER
- Safety of first-line triple therapy with a potassium-competitive acid blocker for Helicobacter pylori eradication in children
- (2017) Chika Kusano et al. JOURNAL OF GASTROENTEROLOGY
- The Efficacy and Tolerability of a Triple Therapy Containing a Potassium-Competitive Acid Blocker Compared With a 7-Day PPI-Based Low-Dose Clarithromycin Triple Therapy
- (2016) Sho Suzuki et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy forHelicobacter pylorieradication: a phase III, randomised, double-blind study
- (2016) Kazunari Murakami et al. GUT
- Role of bismuth in improvingHelicobacter pylorieradication with triple therapy
- (2016) Maria Pina Dore et al. GUT
- Nationwide survey ofHelicobacter pyloritreatment for children and adolescents in Japan
- (2016) Masumi Okuda et al. PEDIATRICS INTERNATIONAL
- Efficacy of Probiotic Supplementation Therapy for Helicobacter pylori Eradication: A Meta-Analysis of Randomized Controlled Trials
- (2016) Muhan LÜ et al. PLoS One
- Metagenomic Analysis of Antibiotic-Induced Changes in Gut Microbiota in a Pregnant Rat Model
- (2016) Imran Khan et al. Frontiers in Pharmacology
- Helicobacter pylori Eradication Causes Perturbation of the Human Gut Microbiome in Young Adults
- (2016) Theresa Wan-Chen Yap et al. PLoS One
- The Effect of Probiotics on Gut Microbiota during theHelicobacter pyloriEradication: Randomized Controlled Trial
- (2015) Bumjo Oh et al. HELICOBACTER
- Low Prevalence and Incidence ofHelicobacter pyloriInfection in Children: A Population-Based Study in Japan
- (2014) Masumi Okuda et al. HELICOBACTER
- Meta-analysis of randomized controlled trials on the efficacy of probiotics in Helicobacter pylori eradication therapy in children
- (2013) Shan Li et al. EUROPEAN JOURNAL OF PEDIATRICS
- UCHIME improves sensitivity and speed of chimera detection
- (2011) Robert C. Edgar et al. BIOINFORMATICS
- Introduction of an examination and treatment for Helicobacter pylori infection in high school health screening
- (2011) Taiji Akamatsu et al. JOURNAL OF GASTROENTEROLOGY
- Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial
- (2011) Peter Malfertheiner et al. LANCET
- Meta-analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment
- (2010) H. Szajewska et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Helicobacter pylori treatment in the era of increasing antibiotic resistance
- (2010) D. Y. Graham et al. GUT
- A human gut microbial gene catalogue established by metagenomic sequencing
- (2010) Junjie Qin et al. NATURE
- QIIME allows analysis of high-throughput community sequencing data
- (2010) J Gregory Caporaso et al. NATURE METHODS
- Short-Term Antibiotic Treatment Has Differing Long-Term Impacts on the Human Throat and Gut Microbiome
- (2010) Hedvig E. Jakobsson et al. PLoS One
- Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample
- (2010) J. G. Caporaso et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now